Terms: = Lymphoma AND SOCS1, O15524, 8651, ENSG00000185338, SOCS-1, SSI-1, SSI1, Cish1, JAB, CISH1, CIS1, TIP3 AND Treatment
25 results:
1. Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics.
Cao B; Sun C; Bi R; Liu Z; Jia Y; Cui W; Sun M; Yu B; Li X; Zhou X
BMC Med Genomics; 2024 Apr; 17(1):84. PubMed ID: 38609996
[TBL] [Abstract] [Full Text] [Related]
2. [CD23 positive, BCL2 rearrangement-negative germinal centre lymphomas].
Menter T; Quintanilla-Martinez L
Pathologie (Heidelb); 2023 Dec; 44(Suppl 3):160-163. PubMed ID: 37932478
[TBL] [Abstract] [Full Text] [Related]
3. Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.
Russler-Germain DA; Krysiak K; Ramirez C; Mosior M; Watkins MP; Gomez F; Skidmore ZL; Trani L; Gao F; Geyer S; Cashen AF; Mehta-Shah N; Kahl BS; Bartlett NL; Alderuccio JP; Lossos IS; Ondrejka SL; Hsi ED; Martin P; Leonard JP; Griffith M; Griffith OL; Fehniger TA
Blood Adv; 2023 Sep; 7(18):5524-5539. PubMed ID: 37493986
[TBL] [Abstract] [Full Text] [Related]
4. [miR-155-5p alleviates lipopolysaccharide-induced inflammatory damage of human SH-SY5Y neuroblastoma cells by down-regulating socs1].
Zhou H; Zhou L; Zhang C; Zhou L; Han Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Mar; 39(3):220-229. PubMed ID: 36946346
[TBL] [Abstract] [Full Text] [Related]
5. [Effect of HDAC Inhibitor Chidamide on PD-L1 Expression in Peripheral T-Cell lymphoma].
Yan MM; Li ZX; Chen C; Zhang W; Zhou DB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1741-1745. PubMed ID: 36476897
[TBL] [Abstract] [Full Text] [Related]
6. Transformation of FL into DLBCL with a PMBL gene expression signature.
Loveday T; Duns G; Rimsza LM; Rech KL; Cook JR; Robetorye RS; Rosenthal AC; Ramsower CA; Yip TK; McKinney CL; Swerdlow SH; Bhavsar S; Steidl C; Gibson SE
Blood Adv; 2023 Mar; 7(6):893-899. PubMed ID: 36240289
[TBL] [Abstract] [Full Text] [Related]
7. socs1 Gene Therapy for Head and Neck Cancers: An Experimental Study.
Kajiyama T; Serada S; Fujimoto M; Ohkawara T; Komori M; Hyodo M; Naka T
Anticancer Res; 2022 Jul; 42(7):3361-3372. PubMed ID: 35790291
[TBL] [Abstract] [Full Text] [Related]
8. Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell lymphomas.
Kim SJ; Kim YJ; Yoon SE; Ryu KJ; Park B; Park D; Cho D; Kim HY; Cho J; Ko YH; Park WY; Kim WS
Cancer Res Treat; 2023 Jan; 55(1):291-303. PubMed ID: 35240014
[TBL] [Abstract] [Full Text] [Related]
9. Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial.
Balasubramanian S; Hodkinson B; Schuster SJ; Fowler NH; Trotman J; Hess G; Cheson BD; Schaffer M; Sun S; Deshpande S; Vermeulen J; Salles G; Gopal AK
Cancer Med; 2022 Jan; 11(1):61-73. PubMed ID: 34791836
[TBL] [Abstract] [Full Text] [Related]
10. [Second-generation Sequencing Analysis of Ph
Liao X; Zou PL; Shen YL; Guo YX; Song L; Xia JW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1101-1108. PubMed ID: 34362488
[TBL] [Abstract] [Full Text] [Related]
11. T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses
Klein K; Witalisz-Siepracka A; Gotthardt D; Agerer B; Locker F; Grausenburger R; Knab VM; Bergthaler A; Sexl V
Front Immunol; 2021; 12():650977. PubMed ID: 34248938
[TBL] [Abstract] [Full Text] [Related]
12. Genomic Alterations and MYD88
Jiang S; Qin Y; Gui L; Liu P; Jiang H; Liu B; Yang J; Yang S; He X; Zhou S; Du X; Yi Y; Lin J; Shi Y
Target Oncol; 2020 Apr; 15(2):221-230. PubMed ID: 32239385
[TBL] [Abstract] [Full Text] [Related]
13. Targeted genotyping of circulating tumor DNA for classical Hodgkin lymphoma monitoring: a prospective study.
Camus V; Viennot M; Lequesne J; Viailly PJ; Bohers E; Bessi L; Marcq B; Etancelin P; Dubois S; Picquenot JM; Veresezan EL; Cornic M; Burel L; Loret J; Becker S; Decazes P; Lenain P; Lepretre S; Lemasle E; Lanic H; Ménard AL; Contentin N; Tilly H; Stamatoullas A; Jardin F
Haematologica; 2021 Jan; 106(1):154-162. PubMed ID: 32079702
[TBL] [Abstract] [Full Text] [Related]
14. [Low-grade dural extranodal marginal zone lymphoma].
Marguet F; Fontanilles M; Bohers E; Derrey S; Langlois O; Veresezan L; Leprêtre S; Sabourin JC; Jardin F; Laquerrière A
Ann Pathol; 2020 Jun; 40(3):243-247. PubMed ID: 31948699
[TBL] [Abstract] [Full Text] [Related]
15. The IL-6 signaling complex is a critical driver, negative prognostic factor, and therapeutic target in diffuse large B-cell lymphoma.
Hashwah H; Bertram K; Stirm K; Stelling A; Wu CT; Kasser S; Manz MG; Theocharides AP; Tzankov A; Müller A
EMBO Mol Med; 2019 Oct; 11(10):e10576. PubMed ID: 31515941
[TBL] [Abstract] [Full Text] [Related]
16. The impact of socs1 mutations in diffuse large B-cell lymphoma.
Mellert K; Martin M; Lennerz JK; Lüdeke M; Staiger AM; Kreuz M; Löffler M; Schmitz N; Trümper L; Feller AC; Hartmann S; Hansmann ML; Klapper W; Stein H; Rosenwald A; Ott G; Ziepert M; Möller P
Br J Haematol; 2019 Dec; 187(5):627-637. PubMed ID: 31407320
[TBL] [Abstract] [Full Text] [Related]
17. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
[TBL] [Abstract] [Full Text] [Related]
18. Phosphorylation of socs1 Inhibits the socs1-p53 Tumor Suppressor Axis.
Saint-Germain E; Mignacca L; Huot G; Acevedo M; Moineau-Vallée K; Calabrese V; Bourdeau V; Rowell MC; Ilangumaran S; Lessard F; Ferbeyre G
Cancer Res; 2019 Jul; 79(13):3306-3319. PubMed ID: 31101761
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.
Song TL; Nairismägi ML; Laurensia Y; Lim JQ; Tan J; Li ZM; Pang WL; Kizhakeyil A; Wijaya GC; Huang DC; Nagarajan S; Chia BK; Cheah D; Liu YH; Zhang F; Rao HL; Tang T; Wong EK; Bei JX; Iqbal J; Grigoropoulos NF; Ng SB; Chng WJ; Teh BT; Tan SY; Verma NK; Fan H; Lim ST; Ong CK
Blood; 2018 Sep; 132(11):1146-1158. PubMed ID: 30054295
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy of intracellular immune checkpoint-silenced DC vaccine.
Wang D; Huang XF; Hong B; Song XT; Hu L; Jiang M; Zhang B; Ning H; Li Y; Xu C; Lou X; Li B; Yu Z; Hu J; Chen J; Yang F; Gao H; Ding G; Liao L; Rollins L; Jones L; Chen SY; Chen H
JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415891
[TBL] [Abstract] [Full Text] [Related]
[Next]